Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9137 USD | +2.65% | +48.33% | +27.43% |
Apr. 26 | VolitionRx Limited Announces Board Changes | CI |
Apr. 23 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
Financials (USD)
Sales 2024 * | 3.63M | Sales 2025 * | 16.48M | Capitalization | 74.99M |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -32M | EV / Sales 2024 * | 18.2 x |
Net cash position 2024 * | 8.9M | Net Debt 2025 * | 18.4M | EV / Sales 2025 * | 5.67 x |
P/E ratio 2024 * |
-2.25
x | P/E ratio 2025 * |
-2.83
x | Employees | 110 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.08% |
Latest transcript on VolitionRx Limited
1 day | +2.65% | ||
1 week | +48.33% | ||
Current month | +20.70% | ||
1 month | +21.86% | ||
3 months | -14.61% | ||
6 months | +24.31% | ||
Current year | +27.43% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Terig Hughes
DFI | Director of Finance/CFO | 54 | 21-01-31 |
Gaetan Michel
COO | Chief Operating Officer | 51 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Martin Faulkes
CHM | Chairman | 80 | 11-10-05 |
Guy Innes
BRD | Director/Board Member | 67 | 11-10-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.9137 | +2.65% | 210,159 |
24-04-25 | 0.8902 | +11.27% | 489,819 |
24-04-24 | 0.8 | -5.88% | 354,848 |
24-04-23 | 0.85 | +41.67% | 3,440,054 |
24-04-22 | 0.6 | -2.60% | 51,117 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.43% | 74.99M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 377M |
- Stock Market
- Equities
- VNRX Stock